Halozyme Therapeutics reported $147.16M in Cash and Equivalent for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
DBV Technologies DBVT:US USD 44.75M 23.46M
Acadia Pharmaceuticals ACAD:US USD 436.58M 296.75M
Agios Pharmaceuticals AGIO:US USD 122.45M 33.91M
Alnylam Pharmaceuticals ALNY:US USD 1.07B 497.67M
Amarin AMRN:US USD 240.5M 12.5M
Amgen AMGN:US USD 9.5B 4.3B
Aptinyx Inc APTX:US USD 66.58M 18.68M
Baxter International BAX:US USD 1.6B 251M
Cara Therapeutics CARA:US USD 42.81M 3.91M
Cytokinetics CYTK:US USD 106.24M 12.61M
Eli Lilly And LLY:US USD 2.62B 5.5M
Esperion Therapeutics ESPR:US USD 159.4M 36.46M
Halozyme Therapeutics HALO:US USD 147.16M 56.23M
Immunogen IMGN:US USD 309.51M 64.36M
Intercept Pharmaceuticals ICPT:US USD 113.2M 55.18M
Intra Cellular Therapies ITCI:US USD 135.36M 58.12M
Intrexon XON:US USD 9.07M 34.78M
Jazz Pharmaceuticals JAZZ:US USD 482.67M 191.74M
Mannkind MNKD:US USD 54.31M 18.8M
Minerva Neurosciences NERV:US USD 40.22M 9.53M
Nektar Therapeutics NKTR:US USD 105.76M 28.21M
Peregrine Pharmaceuticals PPHM:US USD 115.14M 11.03M
Rigel Pharmaceuticals RIGL:US USD 29.87M 2.66M
United Therapeutics UTHR:US USD 966.8M 171.6M
Vanda Pharmaceuticals VNDA:US USD 49.4M 8.83M